Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 2043

Sort by

Sort Order Select

Journal Articles

Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease

Blood (2021) 137 (6): 856–859.

https://doi.org/10.1182/blood.2020008146

Published: 2021

Includes: Supplemental data

Journal Articles

Hydroxyurea: coming to conclusions on safety

David C. Rees

Blood (2021) 137 (6): 728–729.

https://doi.org/10.1182/blood.2020008803

Published: 2021

Journal Articles

There’s safety in numbers

Russell E. Ware, Stephen D. Dertinger

Blood (2021) 137 (6): 729–731.

https://doi.org/10.1182/blood.2020010033

Published: 2021

Journal Articles

Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease

L. Joseph, C. Jean, S. Manceau, C. Chalas, C. Arnaud, A. Kamdem, C. Pondarré, A. Habibi, F. Bernaudin, S. Allali, M. de Montalembert, B. Boutonnat-Faucher, J.-B. Arlet, B. Koehl, M. Cavazzana, J.-A. Ribeil, F. Lionnet, I. Berthaut, V. Brousse

Blood (2021) 137 (6): 826–829.

https://doi.org/10.1182/blood.2020006270

Published: 2021

Journal Articles

Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties

Yohann Garnier, Séverine Ferdinand, Marie Garnier, Kizzy-Clara Cita, Régine Hierso, Aurélie Claes, Philippe Connes, Marie-Dominique Hardy-Dessources, Claudine Lapouméroulie, Nathalie Lemonne, Maryse Etienne-Julan, Wassim El Nemer, Marc Romana

Blood (2020) 136 (2): 247–256.

https://doi.org/10.1182/blood.2020004853

Published: 2020

Includes: Supplemental data

Journal Articles

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic

Robert Sheppard Nickel, Stefanie Margulies, Brittany Frazer, Naomi L. C. Luban, Jennifer Webb

Blood (2020) 135 (25): 2320–2322.

https://doi.org/10.1182/blood.2020006582

Published: 2020

Journal Articles

Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic

Michael R. DeBaun

Blood (2020) 135 (22): 1997–1999.

https://doi.org/10.1182/blood.2020005992

Published: 2020

Journal Articles

The double-edged sword of AlloHCT for SCD

Adetola A. Kassim

Blood (2020) 135 (14): 1083–1085.

https://doi.org/10.1182/blood.2020005118

Published: 2020

Journal Articles

The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib

Jennifer M. O’Sullivan, Angela Hamblin, Christina Yap, Sonia Fox, Rebecca Boucher, Anesh Panchal, Samah Alimam, Helene Dreau, Kieran Howard, Pauline Ware, Nicholas C. P. Cross, Mary Frances McMullin, Claire N. Harrison, Adam J. Mead

Blood (2019) 134 (23): 2107–2111.

https://doi.org/10.1182/blood.2019001861

Published: 2019

Includes: Supplemental data

Journal Articles

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Erica B. Esrick, MD, Maureen Achebe, MD MPH, Myriam Armant, PhD, Pablo Bartolucci, MD PhD, Marioara Felicia Ciuculescu, MD, Heather Daley, Colleen Dansereau, MSN, RN, CPN, Giuseppe Di Caprio, PhD, Bronner Goncalves, MD PhD, Nicolas Hebert, Matthew M Heeney, MD, John M. Higgins, MD PhD, Leslie E. Lehmann, MD, John P Manis, MD, Olivier Negre, PhD, Sarah Nikiforow, MD PhD, Ethan Schonbrun, PhD, David K. Wood, PhD, David A. Williams, MD

Blood (2019) 134 (Supplement_2): LBA-5.

https://doi.org/10.1182/blood-2019-132745

Published: 2019

Journal Articles

Characterization of Community-Based Socioeconomic Factors, Utilization, and Adherence in Children with Sickle Cell Disease

Ronay Thomas, BS, Patrick T. McGann, MD, Andrew Beck, MD MPH, Amanda Pfeiffer, Kyesha M James, BS

Blood (2019) 134 (Supplement_1): 4686.

https://doi.org/10.1182/blood-2019-130637

Published: 2019

Journal Articles

Neuropathic Pain Is Associated with Poor Health-Related Quality of Life in Adolescents with Sickle Cell Disease

Marisa Roman, BA, Janelle Highland, MA, MPP, Dawn Retherford, Amy Pan, PhD, Julie Panepinto, MDMSPH, Amanda M. Brandow, DO, MS

Blood (2019) 134 (Supplement_1): 417.

https://doi.org/10.1182/blood-2019-127626

Published: 2019

Journal Articles

Engagement in Cognitive-Behavioral Therapy for Chronic Pain Management Is Associated with Reductions in Healthcare Utilization in Pediatric Sickle Cell Disease

Soumitri Sil, PhD, Kristina Lai, MPH, Jennifer L. Lee, PhD, Jordan Gilleland-Marchak, PhD ABPP, Beth Thompson, PhD, Lindsey L Cohen, PhD, Peter A. Lane, MD, Carlton Dampier, MD

Blood (2019) 134 (Supplement_1): 418.

https://doi.org/10.1182/blood-2019-130580

Published: 2019

Journal Articles

The Relationship between Mental Health, Educational Attainment, Employment Outcomes, and Pain in Sickle Cell Disease

Kelly M Harris, PhD, Taniya Varughese, MSOT, OTR/L, Anna Bauer, BA, Seth Howdeshell, MD, Cecelia Calhoun, MD, Regina Abel, PhD, Allison A. King, MD MPH, PhD

Blood (2019) 134 (Supplement_1): 419.

https://doi.org/10.1182/blood-2019-129874

Published: 2019

Journal Articles

Optimizing Hydroxyurea Dosing in Sickle Cell Anemia: The Uganda MTD Study

Chandy C. John, MDMS, Robert Opoka, MMED, Teresa Latham, MA, Heather Hume, MDFRCPC, Maria Nakafeero, Phillip Kasirye, Christopher Ndugwa, Adam Lane, PhD, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 520.

https://doi.org/10.1182/blood-2019-125128

Published: 2019

Journal Articles

Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease (SPIN Trial): Final Results

Najibah Aliyu Galadanci, MBBS, MPH, Shehu Umar Abdullahi, MBBS, Shehi Abubakar, MBBS, Aisha Amal Galadanci, MBBS, Halima Bello-Manga, MBBS, MPH, Musa Tabari, MBBS, Binta Jibir, MBBS MPH, Lori Jordan, MD PhD, Adetola A. Kassim, MDMS, Muktar Aliyu, MDMPH DRPH, Michael R. DeBaun, MDMPH

Blood (2019) 134 (Supplement_1): 521.

https://doi.org/10.1182/blood-2019-126474

Published: 2019

Journal Articles

Effects of Hydroxyurea Treatment on Malaria Infections in Sub-Saharan Africa

Peter Olupot-Olupot, George A. Tomlinson, PhD BSc, MSc, Teresa S. Latham, MA, Patrick T. McGann, MD, Brigida Santos, Banu Aygun, MD, Susan Stuber, MA, Leon Tshilolo, MD PhD, Adam Lane, PhD, Thomas N. Williams, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 522.

https://doi.org/10.1182/blood-2019-129251

Published: 2019

Journal Articles

Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia

Blood (2019) 134 (Supplement_1): 615.

https://doi.org/10.1182/blood-2019-123355

Published: 2019

Journal Articles

Thromboembolic Risk Reduction and High Rate of Complete Molecular Response with Long-Term Use of Ropeginterferon Alpha-2b in Polycythemia Vera: Results from a Randomized Controlled Study

Jean-Jacques Kiladjian, MD PhD, Christoph Klade, PhD, Pencho Georgiev, MD, Dorota Krochmalczyk, MD, Liana Gercheva-Kyuchukova, MD, Miklos Egyed, Viktor Rossiev, MD, Petr Dulicek, MD, Árpád Illés, MD D.Sc, Halyna Pylypenko, MD, Lylia Sivcheva, MD, Jiri Mayer, MD, Vera Yablokova, MD, Kurt Krejcy, MD, Hans Hasselbalch, MD, Robert Kralovics, PhD, Heinz Gisslinger, MD

Blood (2019) 134 (Supplement_1): 553.

https://doi.org/10.1182/blood-2019-122233

Published: 2019

Journal Articles

Pegylated Interferon-Alfa Suppresses Clonal Hematopoiesis in Polycythemia Vera and Essential Thrombocythemia and Is Associated with Immune Responses to Tumor Antigens

Tsewang Tashi, MD, Tim Luetkens, MD, Stephanie Avila, Soo Jin Kim, MS, Josef T. Prchal, MD

Blood (2019) 134 (Supplement_1): 1691.

https://doi.org/10.1182/blood-2019-131974

Published: 2019

NARROW

Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease

Hydroxyurea: coming to conclusions on safety

There’s safety in numbers

Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease

Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic

Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic

The double-edged sword of AlloHCT for SCD

The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Characterization of Community-Based Socioeconomic Factors, Utilization, and Adherence in Children with Sickle Cell Disease

Neuropathic Pain Is Associated with Poor Health-Related Quality of Life in Adolescents with Sickle Cell Disease

Engagement in Cognitive-Behavioral Therapy for Chronic Pain Management Is Associated with Reductions in Healthcare Utilization in Pediatric Sickle Cell Disease

The Relationship between Mental Health, Educational Attainment, Employment Outcomes, and Pain in Sickle Cell Disease

Optimizing Hydroxyurea Dosing in Sickle Cell Anemia: The Uganda MTD Study

Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease (SPIN Trial): Final Results

Effects of Hydroxyurea Treatment on Malaria Infections in Sub-Saharan Africa

Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia

Thromboembolic Risk Reduction and High Rate of Complete Molecular Response with Long-Term Use of Ropeginterferon Alpha-2b in Polycythemia Vera: Results from a Randomized Controlled Study

Pegylated Interferon-Alfa Suppresses Clonal Hematopoiesis in Polycythemia Vera and Essential Thrombocythemia and Is Associated with Immune Responses to Tumor Antigens

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only